摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3R,4E)-2',3',4'-tri-O-acetyl-α-L-rhamnopyranosyl-(1'→1)-2-(hexadecaneoylamido)-3-benzoyloxy-octadec-4-ene-1-ol | 914803-37-5

中文名称
——
中文别名
——
英文名称
(2S,3R,4E)-2',3',4'-tri-O-acetyl-α-L-rhamnopyranosyl-(1'→1)-2-(hexadecaneoylamido)-3-benzoyloxy-octadec-4-ene-1-ol
英文别名
(2S,3R,4E)-2',3',4'-tri-O-acetyl-α-L-rhamnopyranosyl-(1'->1)-2-(hexadecanoylamido)-3-O-benzoyl-4-octadecene-1,3-diol
(2S,3R,4E)-2',3',4'-tri-O-acetyl-α-L-rhamnopyranosyl-(1'→1)-2-(hexadecaneoylamido)-3-benzoyloxy-octadec-4-ene-1-ol化学式
CAS
914803-37-5
化学式
C53H87NO11
mdl
——
分子量
914.274
InChiKey
ZHYQAZODVBZNMV-KFOVMZFSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    11.99
  • 重原子数:
    65.0
  • 可旋转键数:
    37.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    152.76
  • 氢给体数:
    1.0
  • 氢受体数:
    11.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2S,3R,4E)-2',3',4'-tri-O-acetyl-α-L-rhamnopyranosyl-(1'→1)-2-(hexadecaneoylamido)-3-benzoyloxy-octadec-4-ene-1-ol甲醇sodium 作用下, 以 二氯甲烷 为溶剂, 反应 10.0h, 以93%的产率得到(2S,3R,4E)-α-L-rhamnopyranosyl-(1'->1)-2-(hexadecanoylamido)-4-octadecene-1,3-diol
    参考文献:
    名称:
    Synthesis of α-l-rhamnosyl ceramide and evaluation of its binding with anti-rhamnose antibodies
    摘要:
    An α-L-rhamnosyl ceramide (1, α-L-RhaCer) has been prepared that was recognized by anti-L-rhamnose (anti-Rha) antibodies. During these studies we explored the use of an α-L-rhamnosyl thioglycoside and a trichloroacetimidate as a glycosyl donors. Subsequently, the acceptors desired for glycosylation, 3-O-benzoylazidosphingosine or 3-O-alloxycarbonylsphingosine, were prepared from D-xylose. The thioglycoside donor, 2,3,4-tri-O-acetyl-1-(4-tolyl)thio-α-L-rhamnopyranoside, and the trichloroacetimidate donor, 2,3,4-tri-O-acetyl-1-(2,2,2-trichloroethanimidate)-α-L-rhamnopyranoside, were synthesized in 50% and 78% yield overall, respectively. The synthesis of the glycosylation acceptor employed an addition-fragmentation olefination that was successfully carried out in 53% yield. With the successful synthesis of key intermediates, α-L-RhaCer (1) was prepared without any insurmountable obstacles. Anti-Rha antibodies were prepared in BALB/c mice by immunizing them with rhamnose-ovalbumin (Rha-Ova) with Sigma Adjuvant System (SAS) and the anti-L-Rha antibodies were isolated from the blood sera. Liposomes and EL4 tumor cells were used as model systems to demonstrate the ability of 1 to insert into a lipid bilayer. The interaction of the liposomes or the EL4 cells with α-L-RhaCer (1) and anti-Rha antibodies were investigated by fluorescence microscopy and flow cytometry, respectively, to confirm the ability of glycolipid 1 to be displayed on the tumor cell surface as well as the ability to be recognized by anti-Rha antibodies.
    DOI:
    10.1016/j.bmc.2014.08.002
  • 作为产物:
    参考文献:
    名称:
    Synthesis of α-l-rhamnosyl ceramide and evaluation of its binding with anti-rhamnose antibodies
    摘要:
    An α-L-rhamnosyl ceramide (1, α-L-RhaCer) has been prepared that was recognized by anti-L-rhamnose (anti-Rha) antibodies. During these studies we explored the use of an α-L-rhamnosyl thioglycoside and a trichloroacetimidate as a glycosyl donors. Subsequently, the acceptors desired for glycosylation, 3-O-benzoylazidosphingosine or 3-O-alloxycarbonylsphingosine, were prepared from D-xylose. The thioglycoside donor, 2,3,4-tri-O-acetyl-1-(4-tolyl)thio-α-L-rhamnopyranoside, and the trichloroacetimidate donor, 2,3,4-tri-O-acetyl-1-(2,2,2-trichloroethanimidate)-α-L-rhamnopyranoside, were synthesized in 50% and 78% yield overall, respectively. The synthesis of the glycosylation acceptor employed an addition-fragmentation olefination that was successfully carried out in 53% yield. With the successful synthesis of key intermediates, α-L-RhaCer (1) was prepared without any insurmountable obstacles. Anti-Rha antibodies were prepared in BALB/c mice by immunizing them with rhamnose-ovalbumin (Rha-Ova) with Sigma Adjuvant System (SAS) and the anti-L-Rha antibodies were isolated from the blood sera. Liposomes and EL4 tumor cells were used as model systems to demonstrate the ability of 1 to insert into a lipid bilayer. The interaction of the liposomes or the EL4 cells with α-L-RhaCer (1) and anti-Rha antibodies were investigated by fluorescence microscopy and flow cytometry, respectively, to confirm the ability of glycolipid 1 to be displayed on the tumor cell surface as well as the ability to be recognized by anti-Rha antibodies.
    DOI:
    10.1016/j.bmc.2014.08.002
点击查看最新优质反应信息

文献信息

  • Efficient Syntheses of a Series of Glycosphingolipids with 1,2‐<i>trans</i>‐Glycosidic Linkages
    作者:Yunpeng Liu、Ning Ding、Hualing Xiao、Yingxia Li
    DOI:10.1080/07328300600859825
    日期:2006.8
    A series of glycosphingolipids with 1,2-trans-glycosidic linkages were synthesized in the presence of neighboring group participation using trichloroacetimidates as glycosyl donors and an azido-sphingosine as the glycosyl acceptor. During the preparation of the target compounds, it was found that the alpha-L-arabinopyranosyl unit in target 7e and intermediates 7b - 7d existed in the C-1(4) conformation and that the b-L-fucopyranosyl unit in 10e adopted the C-4(1) conformation.
查看更多

同类化合物

鞘磷酯 鞘氨醇半乳糖苷-3'-硫酸酯 西高苷 西地芬戈 葡糖鞘氨醇半乳糖苷 葡糖基-N-(2-羟基十八碳酰基)二氢鞘氨醇 脑苷脂类 脑苷脂D 脑苷脂 B 红细胞糖苷酯 神经鞘氨醇半乳糖苷 神经酸酰胺 神经酰胺N-甲基氨基乙基膦酸酯 神经酰胺 神经节苷酯Gm3内酯 神经节苷酯GM1(牛脑) 神经节苷脂GM3 神经节苷脂 溶血神经酰胺三己糖苷 正二十四烷基二氢-葡糖脑苷脂 己酰神经鞘氨醇 大豆脑苷 I 双唾液酸神经节苷酯GD1A 双唾液酸神经节苷脂GD2 单唾液酸神经节苷酯 单唾液酸神经节苷脂GM2 十四酰鞘氨醇 人脾脏葡糖苷酰鞘氨醇 二羟基神经酰胺 二十二烷酰胺,N-[1-[(b-D-吡喃葡萄糖氧基)甲基]-2,3-二羟基-5-十七碳烯基]-2-羟基-(9CI) 二十二烷酰胺,N-[(1S,2R,3E,7E,9E)-1-[(b-D-吡喃葡萄糖氧基)甲基]-2-羟基-8-甲基-3,7,9-十七碳三烯-1-基]-2-羟基-,(2R)- 二十二烷酰胺,N-[(1S,2R,3E)-2-羟基-1-(羟甲基)-3-十五碳烯基]- 乳酰基-N-脂酰基鞘氨醇(牛) 乳糖酰基鞘糖脂 乳糖酰基鞘氨醇 β-D-葡萄糖基C4-神经酰胺 alpha-半乳糖基-C16-神经酰胺 [(E,2S,3R)-3-羟基-2-[[(Z)-十八碳-9-烯酰基]氨基]十八碳-4-烯基]2-三甲基铵乙基磷酸酯盐 [(E,2S,3R)-3-羟基-2-[[(Z)-3-芘-1-基丙-2-烯酰基]氨基]十八碳-4-烯基]2-三甲基铵乙基磷酸酯盐 [(E,2S,3R)-3-羟基-2-[11-(芘-1-基磺酰基氨基)十一烷酰基氨基]十八碳-4-烯基]2-三甲基铵乙基磷酸酯盐 [(E)-2-二甲基氨基-3-羟基十八碳-4-烯基]磷酸二氢酯 [(2R,3S,4S,5R,6R)-3,5-二羟基-2-(羟基甲基)-6-[(E,2S,3R)-3-羟基-2-(二十四烷酰基氨基)十八碳-4-烯氧基]四氢吡喃-4-基]氢硫酸盐 TNPAL-鞘磷脂 O-甘露糖基-(1-3)-O-甘露糖基-(1-4)-O-吡喃葡萄糖基-(1-1)-2-N-二十四烷酰基鞘氨醇 N-(NBD-氨基脲酰)沙丁胺醇 N-辛酰基神经酰胺-1-磷酸酯(铵盐) N-辛酰基4-羟基鞘氨醇(酿酒酵母) N-辛酰基-D-神经鞘氨醇 N-肉豆蔻酰-D-赤型-鞘氨醇 N-肉豆蔻酰-D-赤-鞘氨醇